ORPHEUS

OFFICIAL TITLE: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INCMGA00012 IN ADVANCED PENILE SQUAMOUS CELL CARCINOMA – ORPHEUS

PROJECT DETAILS

ORPHEUS IS AN INTERNATIONAL, MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II CLINICAL TRIAL IN MEN WITH LOCALLY ADVANCED UNRESECTABLE OR METASTATIC PENILE SQUAMOUS CELL CARCINOMA (PSCC).
THE PRIMARY GOAL IS TO ASSESS THE EFFICACY –AS DETERMINED BY THE OBJECTIVE RESPONSE RATE (ORR)– OF INCMGA00012 IN THE STUDY POPULATION.
IN ADDITION, THIS STUDY WILL ALSO EVALUATE THE SAFETY AND TOLERABILITY OF INCMGA00012 IN THESE PATIENTS.

​

​

ORPHEUS AT CLINICALTRIALS.GOV

TUMOR TYPE

PHASE

N

SITES

COUNTRY

STATUS

Start up

ORPHEUS SITES

BACK TO CURRENT PROJECTS